News11/04/2023Regulatory Approvals: the DMF of UMECLIDINIUM BROMIDE has been submitted to FDA under GDUFA procedure
News30/03/2023Interview to Robert Poe, CEO Olon Ricerca Bioscience, published on Global Business Report
News23/03/2023OLON ANNOUNCES THAT ITS RIFAMPICIN DMF IS ELIGIBLE FOR GDUFA PRIOR ASSESSMENT AND IT MEETS THE REQUIREMENTS FOR NITROSAMINE STANDARDS
News22/02/2023Olon announces the completion of the investment to expand the pilot plant capacity in Rodano plant
News20/02/2023OLON AND THE CHEMISTRY DEPARTMENT OF POLITECNICO UNIVERSITY LAUNCH A RESEARCH PROJECT ON POLYMORPHISM
